-
Study aim
-
Determining the diagnostic value of the new device (Breast Light) in comparison with mammography for evaluating breast masses
-
Design
-
The present study is one of the studies evaluating diagnostic tests and screening. All eligible people (including 252 people) will be examined with both Brestlight and mammography diagnostics based on available sampling. Clearly, blinding and randomization do not apply in this study.
-
Settings and conduct
-
In this study, 252 women over the age of 40 who are candidates for breast cancer screening or who have symptoms such as mastalgia, nipple discharge, changes in the appearance of the breast, etc., according to the doctor, need to be screened for diagnostic methods. Initially, the specialist will evaluate the breast tissue using a burst light device in a dark room through direct contact of the probe with the skin of the person. Seeing the dark areas of the cluster indicates malignancy and the results will be recorded by the specialist. They should then be re-examined with a mammogram.
It should be noted that in people who will be diagnosed with the disease will be directed to continue treatment and biopsy.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Women 40 years of age and older, women candidates for breast cancer screening
Exclusion criteria: Reluctance to undergo screening with Brest Light, pregnancy
-
Intervention groups
-
In this study, two diagnostic interventions, Brest Light and mammography, will be used to evaluate breast masses. In this way, all the subjects will be examined first using the new Brest Light diagnostic method, and then mammography will be performed
-
Main outcome variables
-
Primary outcome variables include true positive, true negative, false positive, and false negative of the diagnostic test Brest Light